Research Integrity Crisis

Paul discusses the alarming quality of research surrounding COVID-19 treatments, particularly hydroxychloroquine, highlighting how much of it is unreliable and detrimental to informed decision-making. He shares insights from his experience interacting with government officials, revealing that the president sought his expertise to bridge the gap between the scientific task force and the Oval Office, reflecting a deep mistrust in the prevailing scientific narratives.